D'Orazio & Associates’s GSK GSK Stock Holding History

D'Orazio & Associates’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-338	Closed	-$16K	–	344
2021 Q3	$16K	Buy	338 +176	+109%	+$8.84K	﹤0.01%	450
2021 Q2	$8K	Hold	162	–	–	﹤0.01%	324
2021 Q1	$7K	Hold	162	–	–	﹤0.01%	313
2020 Q4	$7K	Hold	162	–	–	﹤0.01%	284
2020 Q3	$8K	Hold	162	–	–	﹤0.01%	238
2020 Q2	$8K	Buy	162 +2	+1%	+$103	﹤0.01%	250
2020 Q1	$8K	Hold	160	–	–	﹤0.01%	239
2019 Q4	$9K	Hold	160	–	–	﹤0.01%	255
2019 Q3	$9K	Hold	160	–	–	﹤0.01%	257
2019 Q2	$8K	Sell	160 -320	-67%	-$16.1K	﹤0.01%	257
2019 Q1	$25K	Buy	480 +320	+200%	+$16K	0.01%	182
2018 Q4	$8K	Hold	160	–	–	﹤0.01%	231
2018 Q3	$8K	Hold	160	–	–	﹤0.01%	219
2018 Q2	$8K	Hold	160	–	–	﹤0.01%	211
2018 Q1	$8K	Hold	160	–	–	﹤0.01%	212
2017 Q4	$7K	Hold	160	–	–	﹤0.01%	243
2017 Q3	$8K	Hold	160	–	–	﹤0.01%	210
2017 Q2	$9K	Hold	160	–	–	﹤0.01%	236
2017 Q1	$8K	Hold	160	–	–	﹤0.01%	228
2016 Q4	$8K	Hold	160	–	–	﹤0.01%	210
2016 Q3	$8K	Hold	160	–	–	﹤0.01%	206
2016 Q2	$9K	Hold	160	–	–	﹤0.01%	213
2016 Q1	$8K	Buy	+160	New	+$7.97K	﹤0.01%	226
2015 Q4	–	Sell	-160	Closed	-$8K	–	284
2015 Q3	$8K	Hold	160	–	–	﹤0.01%	209
2015 Q2	$9K	Hold	160	–	–	0.01%	187
2015 Q1	$9K	Hold	160	–	–	0.01%	193
2014 Q4	$9K	Hold	160	–	–	0.01%	175
2014 Q3	$9K	Hold	160	–	–	0.01%	177
2014 Q2	$11K	Hold	160	–	–	0.01%	176
2014 Q1	$11K	Sell	160 -3,680	-96%	-$249K	0.01%	172
2013 Q4	$11K	Buy	+3,840	New	+$249K	0.01%	158

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

D'Orazio & Associates's GSK Position: Q4 2021 in Review

D'Orazio & Associates sold out of GSK (GSK) in Q4 2021, closing a stake of 338 shares — an estimated $16K sold.

D'Orazio & Associates first reported a position in GSK in Q4 2013 and held it in 31 quarters. The position peaked at $25K in Q1 2019. 919 funds tracked by Wall St. Rank hold GSK as of Q4 2021.

D'Orazio & Associates reported no remaining GSK position as of Q4 2021 after selling out during the quarter.
D'Orazio & Associates sold 338 GSK shares in Q4 2021, an estimated $16K.
D'Orazio & Associates first reported a position in GSK in Q4 2013 and held it in 31 quarters.
D'Orazio & Associates's GSK position peaked at $25K in Q1 2019.
919 funds tracked by Wall St. Rank held GSK as of Q4 2021.

Based on D'Orazio & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.